[Transient hyperlipidemia secondary to treatment with asparaginase and prednisone].
Losa Frías
V
V
Martín-Sacristán Martín
B
B
Díaz Conejo
R
R
Ramos Corral
R
R
Velasco Arribas
M R
MR
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D008297:Male; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects*
D000970:Antineoplastic Agents; D005938:Glucocorticoids; D001215:Asparaginase; D011241:Prednisone